General Information
Revision date
2022-06-16
Product name
Fesoterodine Fumarate Extended Release tablets
1.2.1 Relevant identified uses
Pharmaceutical product for the treatment of overactive bladder
Manufacturer Name
Annora Pharma Private Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
Section 2
SECTION 2: Hazards identification
Hazard statements
Suspected of damaging the unborn
Precautionary statements
Do not handle until all safety precautions have been read and understood Use personal protective equipment as required IF exposed or concerned: Get medical attention/advice Store locked up Dispose of contents/container in accordance with all local and national regulations
2.3 Other hazards
No data available Note: This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
